Cellnovo Stock

Stocks

CLNV

FR0012633360

Software

Real-time Euronext Paris 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Cellnovo -.--% -

Valuation: Cellnovo

Market Cap 2.44M 2.14M 2M 1.83M 3.43M 233M 3.52M 23.69M 9.26M 115M 9.14M 8.95M 399M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 10.95M 10.22M 9.38M 17.55M 1.19B 17.99M 121M 47.38M 590M 46.77M 45.76M 2.04B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
+0.20%-2.96% - - 20.77B
+0.58%-1.43%-36.70%-8.24% 15.51B
-0.10%+6.49%-48.98%-58.10% 8.02B
+9.99%-9.68%+12.65%+93.54% 6.86B
+3.66%+0.42%-33.02%+242.58% 4.27B
+5.08%-1.31%-32.38%-17.22% 2.29B
+1.10%+4.55%-34.05%-37.31% 1.89B
+0.24%+1.27%+23.76%+85.55% 1.56B
+3.06%+4.67%+7.29%+48.37% 1.39B
Average +2.43%+1.13%-17.68%+43.65% 6.26B
Weighted average by Cap. +1.77%-0.40%-26.50%+28.09%

Financials

2018 2019 *
Net sales 3.32M 2.92M 2.72M 2.5M 4.68M 318M 4.8M 32.31M 12.63M 157M 12.47M 12.2M 544M -
Net income -15.94M -14.01M -13.07M -12M -22.46M -1.53B -23.01M -155M -60.63M -755M -59.84M -58.54M -2.61B -
Net Debt 10.02M 8.81M 8.22M 7.54M 14.12M 960M 14.47M 97.48M 38.12M 475M 37.63M 36.81M 1.64B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock